|Opportunity Name||Genomic Applications Partnership Program|
|Value||$300,000 – $6,000,000|
|Indirect Costs||Eligible at 40% of the partner portion|
|Duration||Up to 2 or 3 years|
Expression of Interest (EOI)
|Draft EOI and fully signed ORS checklist due at SIRI for mandatory review||10-28-2022|
|Draft EOI due at agency||11-01-2022|
|Meeting with agency's review panel||12-06-2022 to 12-09-2022|
|Final EOI and fully signed ORS checklist due to FSc RO at email@example.com for mandatory review||12-30-2022|
|Final EOI and fully signed ORS checklist due at SIRI for mandatory review||01-05-2023|
|Final EOI due at agency||01-09-2023|
|Rehearsal pitch to agency||01-16-2023 to 01-25-2023|
|Pitch to agency||01-23-2023 to 02-06-2023|
Supplementary Proposal (by invitation only)
|Draft supplementary proposal and fully signed ORS checklist due at SIRI for mandatory review||02-23-2023|
|Draft supplementary proposal due at agency||02-27-2023|
|Application and fully signed ORS checklist due to FSc RO at firstname.lastname@example.org for mandatory review||03-28-2023|
|Final application and fully signed ORS checklist due at SIRI for mandatory review||03-31-2023|
|Final supplementary proposal due at agency||04-04-2023|
The GAPP funds downstream research and development (R&D) projects that address real world opportunities and challenges defined by “Receptor” organizations such as industry, government, or not-for-profit entities. These organizations should have the expertise, resources and commitment to commercialize or implement the project’s outcomes. Projects must be active collaborations between the Receptor organization (Canadian or international) and a Canadian academic researcher. Both must play an integral role in the project. These projects are co-funded by Receptors and other stakeholders and must have the potential to generate significant social and/or economic benefits for Canada.
GAPP aims to:
- Accelerate the application of Canadian genomics-derived solutions to real-world opportunities and challenges defined by industry and public sector Receptors.
- Channel Canada’s genomics capacity into sustainable innovations that benefit Canadians.
- Enhance the value of Canadian genomics technologies by de-risking and incentivizing follow-on investment from industry and other partners.
- Foster mutually beneficial collaboration and knowledge exchange between Canadian academia and technology receptors.
To be eligible for the GAPP, a project must:
- Develop and apply a genomics-derived or genomics-enabling tool, product or process to an opportunity or challenge defined by the Receptor(s);
- Focus on late stage R&D that will position the innovation for near-term implementation/commercialization;
- Be co-led by an academic and a Receptor organization in partnership, with active and necessary roles for both; and
- Demonstrate the potential to generate significant social and/or economic benefits for Canada.
How to Apply
All researchers should notify both their Faculty and Diana Frasca (email@example.com) as soon as possible about their intention to apply. Doing so will both streamline the process of securing Faculty-level support for the partnership and ensure that researchers receive adequate support in application preparation.
The SIRI Unit in the Office of Research Services, in collaboration with the corresponding Faculty Research Office, will be supporting the development of applications selected to go forward to Genome Canada. Diana Frasca (firstname.lastname@example.org), Strategic and Institutional Research Initiatives Specialist, will be available to assist your office and your faculty members with any questions regarding the internal and external application processes.
Genome Canada GAPPs are institutional awards and require the support of researchers’ respective Departments, Faculties, Organized Research Units, and the Office of the Vice President Research and Innovation. All researchers planning to submit an EOI for round 25 to Genome Canada are required to submit an ORS Checklist by Oct 28, 2022.